At Polaris Genomics, our team is dedicated to advancing how neuropsychiatric conditions are assessed, diagnosed, and treated by linking neurological and mental health conditions with their underlying biology. 

Our partners bring their passion for change, complementary skills and research expertise to build objective, biology-based tools that rewrite the way we think of mental health and brain health, how we treat mental health and brain health, and ultimately, how we improve the lives of people impacted every step of the way.

Since our founding in 2017, we have developed domestic and international clients and partnerships across multiple sectors, including pharma, health systems, governments, academic, and research organizations.